Debs, Patrick
Dabiri, Mona
Boutin, Robert D.
Smith, Stacy
Link, Thomas M.
Fayad, Laura M.
Funding for this research was provided by:
National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
EMD Serono
Neurofibromatosis Therapeutic Acceleration Program
Article History
Received: 4 August 2025
Revised: 8 October 2025
Accepted: 10 October 2025
First Online: 22 October 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki principles and was submitted to the senior author’s institutional review board (IRB). Because no patient identifiers, protected health information, or sensitive personal data were gathered, the IRB deemed the study exempt from formal review and waived written informed consent.
: The authors declare no competing interests.